Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
AKTS
JANX
Add up to 3 more stocks
AKTS
Aktis Oncology, Inc.
-2.13%
$18.12-0.40Delayed quote: Oct 6, 2026, 1:39 PM EDT
Market Cap
$967.94M
52W Range
$14.72 - $34.19
JANX
Janux Therapeutics, Inc.
+1.24%
$16.74+0.20Delayed quote: Oct 6, 2026, 1:40 PM EDT
Market Cap
$1.02B
52W Range
$12.12 - $35.34
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 2.00 | 1.10 |
| P/S Ratio | 96.22 | 32.03 |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 100.0% | 79.7% |
| Operating Margin | -1149.5% | -1576.7% |
| Net Margin | -727.0% | -321.8% |
| ROE | -15.1% | -11.1% |
| ROA | -13.1% | -10.2% |
| ROIC | -16.5% | -15.2% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 16.33 | 16.35 |
| Quick Ratio | 16.33 | 16.35 |
| Debt/Equity | 0.02 | 0.02 |
| Interest Coverage | N/A | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.